The Translational Genomics Research Institute Findings of a nationwide study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest that a family’s socio-economic status (SES) may influence children’s composition of gut microbiome — the mix of microscopic organisms within the digestive tract. SES includes economic resources such as education, income and occupation, and are […]
IBA Karachi student, Muhammad Jibrail, was expelled from the university for bringing attention to a harassment incident he witnessed between two employees. The post IBA Karachi Expels Student, Muhammad Jibrail, For Highlighting Harassment On Campus appeared first on Runway Pakistan.
CHMP recommends Qinlock to treat adult patients with advanced gastrointestinal stromal tumor – Deciphera Pharmaceuticals
Deciphera Pharmaceuticals, Inc. announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Qinlock (ripretinib) for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with three or more kinase inhibitors, including imatinib. The positive CHMP opinion is a […]
Are you looking for places to visit during your vacations? What better place than Pakistan itself? Here is a list of places in Pakistan you can visit. The post Best Vacation Destinations to Visit in Pakistan in the Upcoming Season appeared first on Runway Pakistan.
Enhertu reduced the risk of disease progression or death by 72% vs. trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer – AstraZeneca + Daiichi Sankyo
Ground-breaking Phase III head-to-head DESTINY-Breast03 results featured at ESMO Presidential Symposium support Enhertu as the potential new standard of care in previously treated patients. DESTINY-Breast01 Phase II trial data also presented at ESMO showed impressive median overall survival of 29.1 months in HER2-positive patients following two or more HER2-based regimens. Detailed positive results from the head-to-head DESTINY-Breast03 Phase III trial […]
Hania Aamir looks ethereal in Allure’s bridal campaign of 2021. We can’t get over the fairytale dresses, aesthetic pictures and gorgeous looks created. The post Hania Aamir Looks Exquisite in Her Allure Bridal Campaign 2021 appeared first on Runway Pakistan.
Imfinzi plus chemotherapy tripled patient survival at three years in the CASPIAN phase III trial in extensive-stage small cell lung cancer – AstraZeneca
Updated results from the CASPIAN Phase III trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with a choice of chemotherapies, etoposide plus either carboplatin or cisplatin, demonstrated a sustained, clinically meaningful overall survival (OS) benefit at three years for adults with extensive-stage small cell lung cancer (ES-SCLC) treated in the 1st-line setting. These data, which show the longest survival update ever […]
GulAhmed’s Winter Collection introduces pops of colors and eye-catching designs, season-friendly fabrics to give you the perfect excuse to step outside. With dozens of options to explore, the only thing you’ll have to worry about is which trend to start with. The post Fashion Trends To Lookout For This Winter Ft. GulAhmed Khaddar & Corduroy Collection 2021 appeared first on […]
The Emmy Nominated Netflix show, Emily in Paris, is back in December 2021 and fans can not wait for it. Here is all we know will happen in Season 2. The post Emily In Paris is Back With Season 2 and Everything We Know About It appeared first on Runway Pakistan.
BioDelivery Sciences International completes acquisition of Elyxyb for acute migraine treatment in the U.S. and Canada
BioDelivery Sciences International, Inc. a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, announced that it has completed the acquisition of U.S. and Canadian rights to Elyxyb (celecoxib oral solution) from Dr. Reddy’s Laboratories Limited. Elyxyb is the first and only FDA-approved ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults. […]